Recursion Pharmaceuticals, Inc. (RXRX) Investor Relations Documents

Recursion Pharmaceuticals, Inc. (RXRX) investor relations documents from the company's IR site: 39 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-05Press releaseRecursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Pro
2026-08-04Press releaseRecursion to Participate in Upcoming Investor Conferences
2026-07-31Press releaseRecursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
2026-07-29Press releaseRecursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
2026-06-17Proxy statementProxy statement
2026-06-02Press releaseRecursion to Participate in Upcoming Investor Conferences
2026-05-29Press releaseRecursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
2026-05-06Press releaseRecursion Reports First Quarter Financial Results and Provides Business Update
2026-05-05Press releaseEarnings Presentation
2026-04-30Press releaseRecursion Announces Board Transition
2026-04-29Press releaseRecursion to Report First Quarter 2026 Business Updates and Financial Results on May 6
2026-04-07Press releaseRecursion to Participate in Upcoming Investor Conferences
2026-02-23Press releaseRecursion to Participate in Upcoming Investor Conferences
2026-02-23Press releaseRecursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
2026-01-06Press releaseRecursion to Present at 44th Annual J.P. Morgan Healthcare Conference
2025-12-01Press releaseRecursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Ad
2025-10-28Press releaseRecursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
2025-07-29Press releaseRecursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
2025-04-28Press releaseRecursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th
2025-02-24Press releaseRecursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th
2024-11-06Press releaseRecursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
2024-10-30Press releaseRecursion to Report Third Quarter 2024 Business Updates and Financial Results on November 6th
2024-08-08Press releaseRecursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
2024-08-08Press releaseRecursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
2024-08-08Press releaseCORRECTION - Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
2024-08-05Press releaseRecursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
2024-06-26Press releaseRecursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
2024-05-02Press releaseRecursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
2024-05-01Press releaseRecursion to Participate in Upcoming Investor Conferences
2024-02-27Press releaseRecursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
2023-11-09Press releaseRecursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
2023-08-08Press releasePress Release
2023-05-08Press releasePress Release
2023-02-27Press releasePress Release
2022-11-08Press releasePress Release
2022-08-09Press releasePress Release
2022-05-10Press releasePress Release
2021-11-10Press releasePress Release
2021-05-12Press releasePress Release
Press releasePress Release

RXRX overview · RXRX earnings · RXRX financials · RXRX KPIs · RXRX ownership · RXRX peers · RXRX filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.